Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxyhydrogen Generator for Acute Exacerbation of COPD
NCT04000451Completed
- Sponsor
- Asclepius Meditec
- Start
- Jan 2019
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Asclepius Meditec. Primary endpoint: Breathlessness, Cough, and Sputum Scale at Day 7. Started Jan 2019; status: completed.
02
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04000451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04000451.